Source prnewswire
NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App
With the FDA's clearance of its innovative artificial intelligence-based Scoliosis Assessment Application, NSite Medical, a leader in the care and treatment of scoliosis, is excited to announce its clearance. This technological breakthrough signifies a major advance in scoliosis diagnosis and management, reinforcing our commitment to cutting-edge scoliosis treatment. In addition, this newly FDA-cleared AI-based Scoliosis Assessment App, a revolutionary tool designed to improve the management and treatment of scoliosis, is the backbone of the National Scoliosis Clinic's management and treatment programs. The purpose of this app is to examine the user's spinal curvature without exposing them to the ionizing radiation of X-rays in order to assess the presence or absence, as well as the severity of the curvature without exposing them to ionizing radiation. Incorporating advanced artificial intelligence technology, the app analyzes critical aspects of scoliosis and provides healthcare professionals and users with a comprehensive view of the current state of the disease.. It is through this process that timely and effective action plans can be formulated, based on the unique spinal profile and symptoms of each individual. As a result of the app's ability to deliver precise and personalized insights, users can take informed steps towards managing their scoliosis, improving the quality of their life, and maximizing their treatment outcomes in a timely manner As a result of the app's ability to deliver precise and personalized insights, users can take informed steps towards managing their scoliosis, improving the quality of their life, and maximizing their treatment outcomes in a timely mannerA new AI-based Scoliosis Assessment App available from the National Scoliosis Clinic has recently been cleared by the FDA and is a revolutionary tool designed to transform the management and treatment of scoliosis, and is the technology that powers the clinic.. Using this app, the user will be able to determine whether the curvature of their spine is present or absent, and the severity of the curvature, without having to expose themselves to any ionizing radiation from a traditional X-ray.. As a result of integrating advanced artificial intelligence (AI) technology, the app analyzes critical aspects of scoliosis and provides both the user and a healthcare professional with a detailed overview of the current state of the condition. In this way, it is possible to formulate timely and effective action plans that are specifically tailored to the unique spinal profile and symptoms of each individual. Due to the app's ability to deliver precise and personalized insights, users will be able to make informed decisions about how to manage their scoliosis, improve their quality of life, and optimize their treatment outcomes by using this app Due to the app's ability to deliver precise and personalized insights, users will be able to make informed decisions about how to manage their scoliosis, improve their quality of life, and optimize their treatment outcomes by using this appThere is a revolutionary tool designed to revolutionize the management and treatment of scoliosis. This tool is known as the Scoliosis Assessment App. A co-founder and CEO of the company, Michael J.. Founder and CEO of scoliosis scanning app, Dr. Kevin Gardner, said, "We are thrilled that the FDA has recently confirmed the safety and efficacy of our AI-based scoliosis scanning app.. It is expected that this will have an immediate impact on scoliosis management pathways for patients, pediatricians, orthopedic surgeons, physical therapists, and other healthcare professionals. Moreover, 68% of adults over the age of 60 also suffer from scoliosis, and this group will benefit from improved health outcomes with the help of the National Scoliosis Clinic and this technology. As a result of this milestone, we have taken a significant step towards our mission of redesigning scoliosis care in a safer, more accessible and patient-centered manner As a result of this milestone, we have taken a significant step towards our mission of redesigning scoliosis care in a safer, more accessible and patient-centered manner A scoliosis patient himself, Kevon Saber, Head of Business Development at NSite, shared the following, "As a scoliosis patient who wasn't diagnosed until his 40s, I know firsthand that most scoliosis patients are not diagnosed or treated in a timely manner,". In addition to the increased curvature of the spine caused by this gap, there are many other problems that can occur, such as adult back pain, which is prevalent among most adults. Using cutting-edge artificial intelligence, we have created a mobile app that democratizes care, allowing anyone who owns a smartphone to be able to access it.According to Steve Avila, MBA, Director of Operations at the company, the FDA's approval enables our company to deliver this novel AI-based software to patients and providers so they can identify scoliosis at an early stage, thereby avoiding complex and costly surgery due to scoliosis.. Our team is looking forward to working with healthcare systems and delivering results for patients as soon as possible.As the co-founder and inventor of the company, Malcolm DeBaun MD, says: "As someone who has witnessed our company's growth since its inception, I am deeply proud of our achievements today.". It is a testament to the hard work and innovative spirit of our team that our product was approved by the FDA."About NSite MedicalPowered by NSite Medical, the National Scoliosis Clinic is leveraging artificial intelligence and telehealth to transform the way scoliosis is diagnosed and managed throughout the country. You can learn more about scoliosis at the following website: https://nationalscoliosisclinic.com.com/.NSite Medical is the source for this information NSite Medical is the source for this information "I am a scoliosis patient who was not diagnosed until I was forty years old, and I know firsthand that most scoliosis patients are not diagnosed and treated in a timely manner," said Kevon Saber, Head of Business Development at NSite. In addition to an increase in spine curvature, this gap can lead to a variety of other problems, including adult back pain, which is commonly experienced by adults. It is our goal to democratize care through cutting-edge artificial intelligence in our mobile application, putting it in the hands of anyone with a smartphone, putting it in their hands." It was also noted that Steve Avila, MBA, Director of Operations, said that "achieving FDA approval allows our company to introduce this novel AI-based software to patients and providers, allowing them to identify scoliosis early in order to reduce the need for complex and costly surgeries." We are thrilled to begin partnering with healthcare systems to deliver results to their patients."As a co-founder and inventor of our company, I am deeply proud of this milestone, as I have observed the company's growth since its inception. The fact that we have achieved FDA clearance is a testament to the hard work and innovative spirit of the entire company."NSite Medical: A Brief OverviewAs part of the National Scoliosis Clinic, powered by NSite Medical, AI and telehealth technology are combining to transform the way scoliosis is diagnosed and treated. For more information, visit https://nationalscoliosisclinic.com/.NSite Medical is the source of this informationGet PRN's top stories and curated news delivered straight to your inbox every week by signing up!
No Comments